đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The goal of this clinical research study is to compare how 2 different drug...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2014-10-13
Trial ID
NCT02269280
A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Status
Completed
Location
Hospital Universitario PrĂncipe de Asturias
Start Date
2020-11-04
Trial ID
NCT04687761
Treatments Being Tested
STUDY BACKGROUND AND PURPOSE: Acute myelogenous leukemia (AML) is a common...
Status
Terminated
Location
Winship Cancer Institute of Emory University
Start Date
2013-11
Trial ID
NCT02234037
Treatments Being Tested
Ziftomenib is an investigational drug in development for the treatment of p...
Status
Recruiting
Location
Mayo Clinic - Phoenix
Start Date
2023-07-18
Trial ID
NCT05735184
Treatments Being Tested
Combining the results of previous studies and based on the clinical practic...
Status
Unknown
Location
The Second Affiliated Hospital of Kunming Medical University.
Start Date
2023-11-01
Trial ID
NCT06073730
This is a study to assess the safety of increasing dose levels of bexmarili...
Status
Active Not Recruiting
Location
City of Hope National Medical Center
Start Date
2022-06-02
Trial ID
NCT05428969
Treatments Being Tested
Bariatric surgery remains the most effective therapy for obesity. Postopera...
Status
Completed
Location
Stony Brook University Hospital
Start Date
2017-08-28
Trial ID
NCT03435003
The purpose of this research study is to test the safety and efficacy of a ...
Status
Recruiting
Location
Brigham and Women's Hospital
Start Date
2026-02-02
Trial ID
NCT07148180
Treatments Being Tested
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
This Phase 1/2 study will evaluate the safety, efficacy, PK, and PD of FT-2...
Status
Completed
Location
UCLA Medical Center
Start Date
2016-04-30
Trial ID
NCT02719574
Treatments Being Tested